GENE ONLINE|News &
Opinion
Blog

2025-03-15|

Older Adults May Have Greater Immunity to H5N1 Avian Flu Virus

by Mark Chiang
Share To

Research conducted at the Perelman School of Medicine at the University of Pennsylvania suggests that older adults may exhibit stronger immune responses to the H5N1 avian influenza virus compared to children. The study found that prior exposure to specific seasonal influenza viruses, particularly those circulating before 1968, is associated with the presence of antibodies capable of binding to the H5N1 virus.

The findings highlight a potential link between historical flu exposures and cross-reactive immunity against avian flu strains. Researchers observed that individuals exposed to earlier seasonal flu viruses were more likely to develop antibodies targeting H5N1. This contrasts with younger populations who lack similar antibody profiles due to their limited exposure to these older strains. The study provides insight into how past viral encounters may influence susceptibility across different age groups when faced with emerging influenza threats.

Date: March, 2025

Newsflash | Powered by GeneOnline AI

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Related Post
Former FDA Commissioner Suggests Vaccination to Protect U.S. Egg Supply from Avian Flu
2025-03-21
Researchers Develop Fluorescent Biosensor to Study Immune Response to DNA
2025-03-20
Study Examines B Cell Mutation Strategies in Antibody Development
2025-03-20
LATEST
The Latest Talk in Cancer Immunotherapy: A Brief Overview of Developments & Current Players in the Exosome Space
2025-04-23
Unlocking the Gut Code: Japan’s Pharmaceutical Sector Explores the Future of Microbiome Therapeutics
2025-04-23
Advancing Pharmaceutical Regulatory Cooperation in Asia: The Vision and Challenges of GMP Inspection Reliance
2025-04-23
The Digital Revolution of Drug Labelling: FHIR and the Global Blueprint for e-Labelling
2025-04-23
Cross-Border Trust and Transparency: The New Landscape of Bridging the Regulatory Review in the Asia-Pacific
2025-04-23
From Cancer to Cosmetics, Physiological to Pathological – The Field of Exosomes Full of Endless Opportunities
2025-04-22
Sumitomo Pharma’s Comeback Story: Reinventing a Century-Old Giant in a Post-Patent Era
2025-04-22
EVENT
2025-04-21
World Vaccine Congress Washington 2025
Washington, U.S.A
2025-04-25
AACR Annual Meeting 2025
Chicago, U.S.A
2025-04-26
SABPA OC/LA 17th Annual Biomedical Forum
Irvine, California, United States
2025-05-03
29th Taiwan Joint Cancer Conference 2025
Taipei, Taiwan
2025-05-05
Swiss Biotech Day 2025
Basel, Switzerland
2025-05-13
ASGCT 28th Annual Meeting 2025
New Orleans, U.S.A.
Scroll to Top